MONTREAL, July 30, 2018 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has received final listing approval for its Bioganix® Gold Series Nutraceuticals on Walmart.com and the products are currently live and available for purchase.
Relevium received today the final product listing approvals by the quality control team at Walmart.com and has begun selling its Bioganix® Gold Series nutraceutical products. As initially announced on May 3, 2018 the Company had received brand approval from Walmart.com to sell in its marketplace and today the Company received final approval for its initial product listing, which are currently live and available for purchase in the United States.
Bioganix® Gold Series is a unique and exclusive line of nutraceutical supplements designed exclusively for discerning health and wellness Walmart.com shoppers. The Company has launched an initial four (4) SKUs comprised of exclusive formulations from some of the highest volume sellers in the Bioganix® product line. The company’s Bioganix Gold Series products includes; Apple Cider Vinegar Capsules, BioPro Advanced Probiotic, Garcinia Cambogia and Pure Forskolin.
Aurelio Useche, CEO of Relevium stated: “The BioGanix® Gold Series is an exclusive Walmart.com line of nutraceuticals and supplements that gives the Company access to a new consumer base” Mr. Useche continued: “Our expectations for the new brand and the Walmart.com channel are high and we believe we will be able to scale the business and expand our available SKUs considerably faster than through our traditional distribution channels”
Abis Hussain, CMO of Relevium, stated: “In the coming months we will establish a working relationship with Walmart as we market our initial batch of products. Depending on demand, available traffic, conversion rates and ultimately profit margins, we will quickly move to launching additional exclusive products to Walmart.com through our Bioganix® Gold Series Nutraceutical brand”
Shareholders should expect updates on the initial performance Walmart.com in Q2 of this fiscal year.
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or brands with a focus on e-commerce in the growing health and wellness sector. The Company, through its wholly-owned subsidiary, Biocannabix Health Corporation, is also incorporating cannabinoids into its nutraceutical strategy and provide its retail customers access to the health benefits of cannabis through its formulations and established brands.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will be able to apply for and ultimately obtain an ACMPR licence, the proposed business of Biocannabix will develop as anticipated, that the Company will raise sufficient funds to develop the Biocannabix business, and that the Company will obtain all requisite regulatory approvals. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed business developments may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche
President and CEO
For more information about this press release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES INC
Email: investors@releviumcorp.com
Website: www.releviumtechnologies.com
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Article source: https://globenewswire.com/news-release/2018/07/30/1543906/0/en/Relevium-s-Bioganix-Gold-Series-Nutraceuticals-Live-on-Walmart-com.html
Often we see people that run or workout, and are kind of overweight, or we ourselves can be overweight but exercise, and think that being fat and fit is good enough. Really the fitness level seems important and your weight isn’t that important. Right?
Well that isn’t really true. You have to lower your fat level as well as get fit to be more healthy
The study results are in. If you want to reduce the risk of dying before your time, being fat and fit isn’t the way to go. Ditto for being slender but not fit. Fat and sedentary is the worst combination, of course. Lean and fit is the best way to live out your years.
Sounds logical, especially in view of all the recent hand-wringing about rising obesity rates. Nevertheless, whether exercise can overcome the risk of being over has been controversial, until now.
Early in 1999, Steven Blair, director of research at the Cooper Institute of Aerobics in Dallas, opined that you can be fat and fit and that would be good enough. In the men who are over or obese, but also moderately or high-fit, we don’t see much increase in the risk of dying, he told Nutrition Action Health Letter.
Can You Be Fat and Fit?
There has been some suggestion that if you are particularly active, you don’t have to worry about your fat, or about your diet, Dr. Frank Hu, lead author of the new study from the Harvard School of Public Health, told the Associated Press. That’s very misleading.
A Harvard study that was large and impressive, encompassing approximately 2.7 million person-years. The researchers followed 116,564 female registered nurses for 24 years. The nurses were 30 to 55 and healthy when the study began in 1976.
The nurses, all non-smokers, were monitored for physical activity and body mass. During the course of the study, 10, 282 died: 2370 from cardiovascular disease, 5223 from cancer, and 2689 from other causes.
The researchers found that being over or obese increased the risk of death regardless of the level of physical activity. Exercise helped, but did not overcome the higher risk of death associated with being fat.
Obese women who did brisk walking or other more rigorous activity three-and-one-half hours or more per week were, nevertheless, almost twice as likely (91 %) to die as those who were both active and lean.
Slender but inactive women were 55% more likely to die. Those who were both sedentary and obese were almost two and one-half times more likely to die.
Women who were both lean and physically active had the lowest mortality, the researchers reported.
Being physically active did not cancel out the increased mortality of over, Dr. Hu stated.
Applauding the Harvard study, Dr. Timothy Church of the Cooper Institute of Aerobics Research told the AP: If you’re lean but you’re sedentary, don’t fool yourself. You’re still at risk. You need to get physically active.
Thin and Fit Is The Way To Live
Another study done by researchers at Imperial college and University College in London. That Study had over 17,000 subjects and found the same thing
Waist circumference was similarly associated with heart disease risk (HR 1.32, 95% CI 1.24 to 1.41). Again, adjusting for blood pressure, cholesterol and diabetes similarly reduced the link so it was on the threshold of significance.
Metabolically healthy obese people had a 28% increased risk of heart disease compared with metabolically healthy normal weight people
Clearly, the best way to live to a ripe old age is to watch what you eat and exercise. According to that research there is no way that you can be fat and fit at the same time.
There has been some suggestion that if you are particularly active, you dont have to worry about your body, about your diet, Dr. Frank Hu, lead author of the new study from the Harvard School of Public Health, told the Associated Press. Thats very misleading.
The Harvard study was large and impressive, encompassing approximately 2.7 million person-years. The researchers followed 116,564 female registered nurses for 24 years. The nurses were 30 to 55 and healthy when the study began in 1976. The nurses, all non-smokers, were monitored for physical activity and body mass. During the course of the study, 10, 282 died: 2370 from cardiovascular disease, 5223 from cancer, and 2689 from other causes.
The researchers found that being over or obese increased the risk of death regardless of the level of physical activity. Exercise helped, but did not overcome the higher risk of death associated with being fat.
Obese women who did brisk walking or other more rigorous activity three-and-one-half hours or more per week were, nevertheless, almost twice as likely (91 %) to die as those who were both active and lean. Slender but inactive women were 55% more likely to die. Those who were both sedentary and obese were almost two and one-half times more likely to die.
Women who were both lean and physically active had the lowest mortality, the researchers reported.
Being physically active did not cancel out the increased mortality of over, Dr. Hu stated.
Applauding the Harvard study, Dr. Timothy Church of the Cooper Institute of Aerobics Research told the AP: If youre lean but youre sedentary, dont fool yourself. Youre still at risk. You need to get physically active.
Clearly, the best way to live to a ripe old age is to watch what you eat and exercise.
Article source: https://www.fitnesstipsforlife.com/its-important-to-be-thin-and-fit-not-just-fit.html
In April 2018, ASCI’s Consumer Complaints Council (CCC) upheld complaints against 89 advertisements out of the total of 162 advertisements that were evaluated by the CCC.
Out of the total 89 advertisements against which complaints were upheld, 24 belonged to the healthcare sector, 34 to the education sector, 20 to the food beverages category, two to the personal care and nine were from the ‘others’ category. A total of 101 advertisements were picked up by ASCI’s suo moto surveillance, wherein 31 cases were informally resolved as advertisements were voluntarily withdrawn and objections against 68 advertisements were upheld. Of the 61 advertisements complained against by the general public or by industry members, 12 cases were informally resolved wherein the advertisements were voluntarily withdrawn and complaints against 21 advertisements were upheld by the CCC.
ALSO READ: ASCI Update: Complaints against 232 out of 305 ads are upheld
Exaggeration of product efficacy was the number one reason for upholding complaints. The other reasons included providing facts and figures which were inadequate to substantiate claims, exploiting consumers’ lack of knowledge, claims which were misleading by gross exaggeration and delivering advertisements which were misleading by ambiguity or by implication. This was followed by violations of the Drugs and Magic Remedies Act (DMR Act) and the Drugs and Cosmetics (DC) Rules and advertisements which contravened various ASCI guidelines.
Among the various complaints against advertisements, the CCC observed that a popular smartphone company was found to unethically attract customers by claiming the biggest sale ever in the history of India. Several advertisements used logos of AYUSH or FSSAI in their communication which was considered to be inappropriate as all AYUSH products in the market are required to have approval from the State Licensing authorities and calling it out separately as a claim, is misleading by implication that Ministry of AYUSH or FSSAI has approved the product efficacy/ claims made in the advertisement.
Shweta Purandare
“ASCI’s work in monitoring Print and TV advertisements for the AYUSH sector has also been recognized by the Parliamentary Standing Committee on Health Family Welfare. The committee was of the view that collaborative efforts of the ministry, along with the DoCA, MIB and State Governments, have certainly given results as misleading advertisements, with respect to AYUSH drugs, which have been unregulated so far, have been controlled to an extent. ASCI’s inclusion in the AYUSH’s empowered committee earlier this year is a reflection of regulators’ recognition of ASCI’s consistent efforts to curb misleading advertisements” says Shweta Purandare, secretary general of ASCI.
A total of 24 advertisements were complained against in the healthcare segment. While direct complaints include five advertisements, suo moto surveillance by ASCI, picked up 19 advertisements complained against. In personal care, a total of two advertisements complained against were direct complaints.
Twenty advertisements were complained against in the food and beverages segment. Direct Complaints were made against five advertisements while suo moto surveillance by ASCI picked 15 advertisements.
The Education segment drew a Total of 34 advertisements. Direct Complaints were made against four advertisements. Suo Moto Surveillance by ASCI picked 30 advertisements,
A total of nine advertisements were complained against in the others segment of which direct complaints were made against five advertisements and the rest were picked via Suo Moto Surveillance by ASCI.
DIRECT COMPLAINTS:
FOOD AND BEVERAGES:
Mobius Foundation/ Ayurvet Limited (Antibiotics in Chicken), All India Poultry Development and Service. Perfetti Van Melle India Pvt. Ltd (Chupa Chup Sour Strip and Sour Bite), Oshun Food Products Private Ltd (Native Milk), Nutravo Lifecare Pvt Ltd (Nutralyfe Garcinia Cambogia Herbs).
HEALTHCARE:
Jolly Healthcare (Jolly Vaseir), Shape in Slimming Centre, Aura Weight Loss Clinic, A R Ayurveda Pvt. Ltd (Ashwa Shakti powder), Greek Retail P. Limited (Refollium Capsules),
PERSONAL CARE:
The Himalaya Drug Company (Himalaya Youth Eternity under Eye Cream), The Promen.in (Promen Lip Lightener)
EDUCATION:
LegalEdge Tutorials, National Institute of Fire Safety Engineering (NIFSE), National Academy Of Fire and Safety Engineering (NAFS), Fortune Computer Academy
OTHERS:
Xiaomi Logistics, Magicon Impex Pvt Ltd (Jivi Mobiles), Yamaha Motor Pvt Ltd (Yamaha FZ), Walter Bushnell (Uriliser), Tata Steel Ltd (Tata Pipes)
SUO MOTO Surveillance by ASCI
FOOD BEVERAGE:-
Swad Food Products (Swad Adatt Matta Rice), Flipbald Health and Wellness Products (Flipbald De-addiction Powder), Flipbald Health and Wellness(Flipbald De-addiction Powder), Flipbald Health and Wellness (Flipbald Green Coffee Beans and Forme Oil), Flipbald Health and Wellness Products (Flipbald De-addiction Powder) Ganga Milk Foods (Ganga Shahi Kheer), Anil Foods (New Range of Millet Vermicellis), Super Salt Pvt Ltd (Top Line Activ Natural Salt), Super Salt Pvt Ltd (Top Line Activ Natural Salt), Super Salt Pvt Ltd (Top Line Activ Natural Salt), Bhopal Sahakari Dugdha Sangh (Sanchi Milk), Saboo Sodium Chloro Limited (Surya Salt), Paras Mushroom.
HEALTHCARE:-
Slim N Slender, Olivia Skin Hair Clinic, Sah Hospital, ILS Hospital, Ranjeet Goswami Memorial Homeopathic Hospital, Aesthetica Implant Clinics Dental, Rediscover Clinic, Lotus Slimming Centre Pvt Ltd (Figure First), Dr Paiwal Physiotherapy Clinic, D.S Research Centre, Kaya Komal Avleh, Naturoveda India Pvt Ltd Naturoveda Health World, Naturoveda India Pvt Ltd (Naturoveda Health World), Arogyam Ayurvedic Centre (Allergy Rakshak Range of Products, Ayurwin Pharma Private Limited (Nutrigain Plus Range of Products – Capsules Powder) Ayurwin Pharma Private Limited (Nutrigain Plus Range of Products – Capsules Powder) Flipbald Health Wellness (Flipbald De-addiction powder) Flipbald Health Wellness (Flipbald De-addiction powder), Flipbald Health Wellness (Flipbald De-addiction powder).
EDUCATION:-
Law Prep Tutorial, Winner Institute, Maharashtra Academy of Engineering and Educational Research Vishwashanti Gurukul, Sham Kaushalya Taneja Educational Society – Taneja Public School, Rao Edusolutions Pvt Ltd Rao IIT Academy, DAV College Managing Committee, International Institute of Fashion Design, Karnel Academy.
Complaints against advertisements of 22 educational institutes listed below are UPHELD mainly because of unsubstantiated claims and/ or misleading claims that they provide 100 per cent placement/ placement assistance and/ or they claim to be the No.1 in their respective fields.
X-EEED Coaching, Vinayak Classes, Saraswati Institute of Career Studies, Patliputra Coaching Classes, Pai Defence Academy, Nice Study Circle, Institute For Competitive Exam, Marwad Defence Academy, Bansal Classes Pvt Ltd, Deeksha College of Commerce, Institute of Account Management Studies – Institute of Accounts and Management Business School, Ayyappa Constable Coaching Center, The Sumana Foundation /School of Indian Hotel Management, Kautilya Academy, Brills Institute, Delhi Public School, A B Foundation, Safal Academy , Shrestha Samajik Seva Sansthan Samiti – Shrestha Private Ltd, Image Infotainment Ltd (Image Computer Education), Jagat Narain Romesh Chander Educational Trust (J.R. Media Institute), Excellent Civil Academy.
OTHERS:-
Confident Group (Confident Canopus), Maa Kamakhavya Darbar Fragrances India Pvt. Ltd (Tiranga Sacred Agarbatti), Jet Knitwear (Jet Lycot Readymades), ARG Outlier Media Asianet News Pvt Ltd Republicworld.com.
For feedback/comments, please write to newsteam@afaqs.com
First Published : July 27, 2018 06:51 AM
Article source: http://www.afaqs.com/news/story/53355_ASCI-upholds-complaints-against-89-advertisements-out-of-162